Adequan Canine 100 mg/ml 2 x 5 ml
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
The only PSGAG approved disease-modifying OA drug (DMOAD), Adequan® Canine (polysulfated glycosaminoglycan) empowers you to treat the disease and not just the clinical signs of canine osteoarthritis. For intramuscular use in dogs. Each mL of Adequan® Canine contains 100 mg Polysulfated Glycosaminoglycan (PSGAG), 0.009 mL benzyl alcohol as a preservative, and water for injection. Adequan® Canine is recommended for the treatment of non-infectious degenerative and/or traumatic arthritis and associated lameness of canine synovial joints. 2 x 5 ml multiple dose vials per box
Product Details
| DIN (Drug Identification Number) | 02052415 |
| Active Ingredients | 100 mg Polysulfated Glycosaminoglycan (PSGAG) |
| Approved For | Dog |
| Therapeutic Use | Chondroprotectant |
| Form | Solution |
| Route of Administration | Intramuscular |
| Strength / Concentration | 100 mg/ml mg/ml |
| Pack Size | 2 x 5 ml |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | American Regent |
|---|---|
| DIN | 2052415 |
| Active Ingredient | 100 mg Polysulfated Glycosaminoglycan (PSGAG) |
| Strength | 100 mg/ml mg/ml |
| Pack Size | 2 x 5 ml |
Storage & Shipping
| Shipping Weight | 0.042 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
